Food and Drug Regulations (C.R.C., c. 870)

Regulations are current to 2014-07-22 and last amended on 2014-05-16. Previous Versions

 Notwithstanding section D.02.005, no person shall make any claim with respect to the iron content of a human milk substitute except as required by paragraph B.25.057(1)(c), unless the human milk substitute contains at least one milligram of iron per 100 available kilocalories.

  • SOR/78-637, s. 9(F);
  • SOR/83-933, s. 1.

 No person shall, on the label of or in any advertisement for a human milk substitute or a food represented as containing a human milk substitute, make any statement or claim relating to the content in the food of

  • (a) the percentage of the daily value of

    • (i) fat,

    • (ii) saturated fatty acids and trans fatty acids,

    • (iii) sodium,

    • (iv) potassium,

    • (v) carbohydrate,

    • (vi) fibre, or

    • (vii) cholesterol; or

  • (b) the number of Calories from

    • (i) fat, or

    • (ii) saturated fatty acids and trans fatty acids.

  • SOR/2003-11, s. 26.
  •  (1) Where the manufacturer of a human milk substitute or of a food that is represented as containing a human milk substitute is requested in writing by the Director to submit on or before a specified day evidence with respect to the human milk substitute, the manufacturer shall make no further sales of that human milk substitute or food that is represented as containing human milk substitute after that day unless he has submitted the evidence requested.

  • (2) Where the Director is of the opinion that the evidence submitted by a manufacturer pursuant to subsection (1) is not sufficient, he shall notify the manufacturer in writing that the evidence is not sufficient.

  • (3) Where, pursuant to subsection (2), a manufacturer is notified that the evidence with respect to the human milk substitute is not sufficient, he shall make no further sales of that human milk substitute or of that food that is represented as containing the human milk substitute unless he submits further evidence and is notified in writing by the Director that the further evidence is sufficient.

  • (4) In this section, “evidence with respect to the human milk substitute” means

    • (a) evidence that establishes that the human milk substitute is nutritionally adequate to promote acceptable growth and development in infants when consumed in accordance with the directions for use; and

    • (b) the results of tests carried out to determine the expiration date of the human milk substitute.

  • SOR/83-933, s. 1;
  • SOR/88-424, s. 2;
  • SOR/90-174, s. 3.
  •  (1) Subject to subsection (2), no person shall include on the label of a food any representation respecting the consumption of the food by an infant who is less than six months of age.

  • (2) Subsection (1) does not apply in respect of a human milk substitute or a new human milk substitute.

  • SOR/83-933, s. 1;
  • SOR/90-174, s. 4.